Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q411799> ?p ?o }
Showing triples 1 to 68 of
68
with 100 triples per page.
- Q411799 subject Q8412954.
- Q411799 subject Q8645495.
- Q411799 subject Q8878420.
- Q411799 subject Q8949762.
- Q411799 subject Q9134654.
- Q411799 abstract "Levacetylmethadol (INN), levomethadyl acetate (USAN), OrLAAM (trade name) or levo-α-acetylmethadol (LAAM) is a synthetic opioid similar in structure to methadone. It has a long duration of action due to its active metabolites. It was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. In 2001, Orlaam was removed from the European market due to reports of life-threatening ventricular rhythm disorders. In 2003, Roxane Laboratories, Inc. discontinued Orlaam in the US.".
- Q411799 atcPrefix "N07".
- Q411799 atcSuffix "BC03".
- Q411799 casNumber "1477-40-3".
- Q411799 casSupplemental "(hydrochloride)".
- Q411799 drugbank "15130".
- Q411799 fdaUniiCode "R3B637Y991".
- Q411799 iupacName "(3S,6S)-(6-dimethylamino-4,4-diphenyl-heptan-3-yl) acetate".
- Q411799 pubchem "15130".
- Q411799 thumbnail Levacetylmethadol_Formula_V.1.svg?width=300.
- Q411799 wikiPageExternalLink ?aModele=afficheN&cpsidt=2390242.
- Q411799 wikiPageExternalLink ?aModele=afficheN&cpsidt=2706063.
- Q411799 wikiPageExternalLink getCard.cgi?CARD=APRD00745.txt.
- Q411799 wikiPageExternalLink levomethadyl.html.
- Q411799 wikiPageExternalLink levomethadyl_wcp.htm.
- Q411799 wikiPageWikiLink Q1057.
- Q411799 wikiPageWikiLink Q12029.
- Q411799 wikiPageWikiLink Q14911924.
- Q411799 wikiPageWikiLink Q15318.
- Q411799 wikiPageWikiLink Q16.
- Q411799 wikiPageWikiLink Q179996.
- Q411799 wikiPageWikiLink Q182854.
- Q411799 wikiPageWikiLink Q189331.
- Q411799 wikiPageWikiLink Q1985205.
- Q411799 wikiPageWikiLink Q204711.
- Q411799 wikiPageWikiLink Q2080426.
- Q411799 wikiPageWikiLink Q274160.
- Q411799 wikiPageWikiLink Q389934.
- Q411799 wikiPageWikiLink Q407595.
- Q411799 wikiPageWikiLink Q407721.
- Q411799 wikiPageWikiLink Q408.
- Q411799 wikiPageWikiLink Q412256.
- Q411799 wikiPageWikiLink Q420060.
- Q411799 wikiPageWikiLink Q427523.
- Q411799 wikiPageWikiLink Q4673310.
- Q411799 wikiPageWikiLink Q4734890.
- Q411799 wikiPageWikiLink Q4735230.
- Q411799 wikiPageWikiLink Q4926095.
- Q411799 wikiPageWikiLink Q5447188.
- Q411799 wikiPageWikiLink Q6535776.
- Q411799 wikiPageWikiLink Q824258.
- Q411799 wikiPageWikiLink Q8412954.
- Q411799 wikiPageWikiLink Q8645495.
- Q411799 wikiPageWikiLink Q8878420.
- Q411799 wikiPageWikiLink Q8949762.
- Q411799 wikiPageWikiLink Q9134654.
- Q411799 wikiPageWikiLink Q928770.
- Q411799 wikiPageWikiLink Q9635.
- Q411799 atcPrefix "N07".
- Q411799 atcSuffix "BC03".
- Q411799 casNumber "1477".
- Q411799 drugbank "15130".
- Q411799 iupacName "- acetate".
- Q411799 pubchem "15130".
- Q411799 unii "R3B637Y991".
- Q411799 type ChemicalSubstance.
- Q411799 type Drug.
- Q411799 type ChemicalObject.
- Q411799 type Thing.
- Q411799 type Q8386.
- Q411799 comment "Levacetylmethadol (INN), levomethadyl acetate (USAN), OrLAAM (trade name) or levo-α-acetylmethadol (LAAM) is a synthetic opioid similar in structure to methadone. It has a long duration of action due to its active metabolites. It was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. In 2001, Orlaam was removed from the European market due to reports of life-threatening ventricular rhythm disorders. In 2003, Roxane Laboratories, Inc.".
- Q411799 label "Levacetylmethadol".
- Q411799 depiction Levacetylmethadol_Formula_V.1.svg.